Exercise in Cancer Care

Established mechanisms are the ordinary physiology of training: aerobic and resistance exercise improve cardiorespiratory fitness, preserve and rebuild skeletal muscle against treatment-related wasting, and reduce cancer-related fatigue and improve physical function and mood, effects measured directly in trials. The proposed and still-contested mechanisms concern how exercise might slow cancer itself: candidate pathways that proponents describe include lowered circulating insulin and inflammation, shifts in immune cell trafficking, improved tumor blood flow and oxygenation that may sensitize tumors to therapy, and better completion of and tolerance to chemotherapy. Researchers describe these tumor-directed mechanisms as largely supported by preclinical and associative human data, characterizing them as plausible rather than settled.

Most of the published research on this comes from one place. 90% of it is from North America. Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Movement prescribed as medicine reaches back to the daoyin ("guiding and pulling") breathing and stretching routines of China, documented from at least the 3rd century BCE and depicted on the Mawangdui silk Daoyin tu (c. 168 BCE), and to the therapeutic postures and breath work of hathayoga developed across the Indian subcontinent, with the surgical compendium attributed to Susruta (Susruta Samhita, roughly mid-first millennium BCE to early CE) advising regulated physical activity to maintain health. These Asian self-cultivation traditions traveled along Silk Road and maritime routes and cross-pollinated, the Chinese daoyin and Indian yogic practices sharing a recognizable family resemblance. Greco-Roman medicine added its own thread, with Herodicus and later Galen prescribing graded exercise, and Persian physicians including Avicenna (Ibn Sina) systematizing exercise dosing in the Canon of Medicine (c. 1025 CE). The narrow application to cancer is recent and Western-led, emerging only after oncologists abandoned the long-standing advice that patients should rest and conserve energy.

The use of movement as medicine is ancient and non-Western in origin, with Chinese daoyin therapeutic gymnastics and Indian yogic and Ayurvedic regimens prescribing regulated activity for health more than two thousand years ago, and Persian and Greco-Roman physicians later codifying exercise dosing. The specific application to cancer is a twentieth and twenty-first century development. Through much of the twentieth century, prescribed bed rest and energy conservation were standard advice for cancer patients. That began to change in the late 1980s and 1990s as small trials, several led by researchers in North America and Europe, reported that supervised aerobic exercise reduced fatigue and improved function during chemotherapy. The 2010 ACSM roundtable first declared exercise safe and beneficial for survivors, the 2019 update issued condition-specific prescriptions, and the 2025 CHALLENGE trial and 2026 ESMO update moved exercise from supportive care toward adjuvant therapy for colon cancer.

1. c. 168 BCEMawangdui Daoyin tu silk chart depicts Chinese therapeutic exercise postures, among the oldest records of movement as medicine
2. c. 1025 CEAvicenna's Canon of Medicine systematizes graded exercise dosing, building on earlier Indian, Chinese, Persian, and Greco-Roman traditions
3. 2010ACSM roundtable declares exercise safe and beneficial for cancer survivors, formally reversing rest-only advice
4. 2019ACSM International Multidisciplinary Roundtable issues condition-specific exercise prescriptions for fatigue, quality of life, function, anxiety, depression, and lymphedema
5. 2025 to 2026CHALLENGE phase III trial (NEJM 2025) reports survival benefit in colon cancer; ESMO publishes guideline express update in January 2026

Exercise oncology draws on movement traditions that are themselves living cultural property, including Chinese qigong and Indian yoga, but the clinical field as practiced today is a secular biomedical rehabilitation discipline rather than an extraction of any single ceremonial tradition.

Primary class

Movement and prescribed exercise (supportive and, in colon cancer, adjuvant oncology care)

Key guideline

ACSM 2019 International Multidisciplinary Roundtable; ESMO localized colon cancer express update, January 2026

Landmark trial

CHALLENGE (CCTG CO.21), NEJM 2025: structured exercise reported to improve disease-free survival in resected colon cancer (HR about 0.72)

Typical prescription

Moderate aerobic exercise about 3 times per week plus resistance training 2 to 3 times per week, individualized and supervised

What follows is unfinished work on our side, not a finding about Exercise in Cancer Care. A short entry is not a safe entry.

• Cost and market. We have not documented what it sells for or who sells it.
• Supply chain. We have not mapped where it is made.
• Who uses it. We have not documented the user groups.
• What could change. No forward-looking summary yet.
• How it compares. We have not set it against the alternatives.
• Children and teenagers. We have not checked what is known about younger people.
• What people take it for. We have not catalogued the claims made for it.